Projects per year
Personal profile
Biography
Keng Yoon Yeong (Ken) is currently the Associate Head (Industry Engagement and Enterprising) and a Senior Lecturer in the School of Science where he teaches Medicinal Chemistry and Advanced Organic Chemistry. Ken’s research focuses on medicinal chemistry with intersections to organic synthesis, biology and medicine. Broadly, the theme of Ken’s research group is targeted towards small molecule and short peptide drug discovery.
Before joining Monash University, Ken has spent 11 years as a research scientist in industry where he worked on small molecule organic synthesis and immunoassays. He has co-authored over 60 research publications in the field of medicinal chemistry and drug discovery. His group’s research activities are supported by supported by international as well as national funders such as the Royal Society of Chemistry UK, Malaysian Ministry of Science, Technology and Innovation (MOSTI) and Malaysian Ministry of Higher Education (MOHE). He is a co-inventor for 7 patent applications and is the recipient of numerous academic awards.
Research interests
- Small molecule drug discovery
Synthesis of interesting chemical scaffolds targeting cancers, infectious diseases and neurological disorders. Our group uses a parallel synthesis approach to generate libraries of compounds. An area of current interest is in retooling old drugs through rational drug design. Design strategies for synthesis include computer-aided-drug-design, SAR, hybridisation and bioisosteric replacements.
- Short peptide drug discovery
Synthesis of short peptides targeting cancers, infectious diseases and neurological disorders. Our group uses solid-phase-peptide-synthesis (SPPS) method to generate series of short peptides. Short peptides can act as therapeutics or as fragments to improve the physicochemical characteristics of biologically active molecules.
- Semi-synthesis of bioactive compounds
Semi-synthesis of naturally occurring bioactive compounds of interest to improve their pharmacological properties.
Research interests
- CHM3930 (Medicinal chemistry)
- CHM3922 (Advanced organic chemistry)
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Collaborations and top research areas from the last five years
-
Development of ADAR1 inhibitors for the treatment of oral cancers
Yeong, K. Y. (Chief Investigator (CI)), Chai, W. Y. (Primary Chief Investigator (PCI)), Cheong, S. C. (Chief Investigator (CI)), Yee, P. S. (Chief Investigator (CI)), Chee, X. W. (Chief Investigator (CI)) & Ng, S. K. (Chief Investigator (CI))
1/09/24 → 31/08/26
Project: Research
-
VOLATEVS - Analysis of the volatile organic compounds emitted by extracellular vesicles for disease diagnosis
Lee, W.-L. (Primary Chief Investigator (PCI)), Hing, G. B. (Chief Investigator (CI)) & Yeong, K. Y. (Chief Investigator (CI))
1/11/22 → 31/10/26
Project: Research
-
Isolation of bioactive compounds from the methanol extract of Myristica fragrans and their potential application in managing Alzheimer's Disease
Yeong, K. Y. (Primary Chief Investigator (PCI))
4/04/24 → 3/04/25
Project: Research
-
Development of a new receptor-targeted fluorescent probe and its mechanistic study as a potential for breast cancer imaging
Htar, T. T. (Primary Chief Investigator (PCI)), Chow, S. C. (Chief Investigator (CI)), Naidu, R. (Chief Investigator (CI)), Ahemad, N. (Chief Investigator (CI)), Chuah, A. (Chief Investigator (CI)) & Yeong, K. Y. (Chief Investigator (CI))
1/11/20 → 31/10/24
Project: Research
-
Design, synthesis and mechanistic studies of novel benzimidazole sirtuin inhibitors as a novel class of therapeutics against drug-resistant oral cancer cells
Yeong, K. Y. (Primary Chief Investigator (PCI)), Ahemad, N. (Chief Investigator (CI)), Lee, W.-L. (Chief Investigator (CI)), Osman, H. (Chief Investigator (CI)), Yuen Lin, C. (Chief Investigator (CI)) & Hock Siew, T. (Chief Investigator (CI))
1/11/20 → 30/10/24
Project: Research
-
The underutilized therapeutic potential of cyclic sulfonamides
Yeong, K. Y. & Ang, C. W., 9 Sept 2025, In: Future Medicinal Chemistry. 17, 19, p. 2311-2313 3 p.Research output: Contribution to journal › Editorial › Other › peer-review
Open Access -
Indazole derivatives as selective inhibitors of butyrylcholinesterase with effective blood-brain-barrier permeability profile
Tobuse, A. J., Law, C. S. W., Thy, C. K., James, J. J., Chee, C. F. & Yeong, K. Y., Feb 2024, In: Medicinal Chemistry Research. 33, 2, p. 298-307 10 p.Research output: Contribution to journal › Article › Research › peer-review
3 Citations (Scopus) -
Shaping the future of antiviral Treatment: Spotlight on Nucleobase-Containing drugs and their revolutionary impact
Wong, X. K., Ng, C. S. & Yeong, K. Y., Mar 2024, In: Bioorganic Chemistry. 144, 46 p., 107150.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access3 Citations (Scopus) -
Anti-Amyloid β Aggregation Activity and Cell Viability Effect of Betacyanins from Red Pitahaya (Hylocereus polyrhizus) for Alzheimer’s Disease
Thwe, P. N., Yeong, K. Y. & Choo, W. S., Sept 2023, In: Plant Foods for Human Nutrition. 78, 3, p. 613-619 7 p.Research output: Contribution to journal › Article › Other › peer-review
8 Citations (Scopus) -
Linking Diabetes to Alzheimer's Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase
Wee, A. S., Nhu, T. D., Khaw, K. Y., Tang, K. S. & Yeong, K. Y., 2023, In: Current Neuropharmacology. 21, 10, p. 2036-2048 13 p.Research output: Contribution to journal › Article › Research › peer-review
16 Citations (Scopus)
Prizes
-
Faculty of Science Dean's Award for Excellence in Honours Supervision
Yeong, K. Y. (Recipient), 2023
Prize: Prize (including medals and awards)
-
Faculty of Science Dean's Award for Excellence in Teaching
Yeong, K. Y. (Recipient), 2020
Prize: Prize (including medals and awards)
-
From grave to cradle: Hunting new antimicrobials through sustainable drug discovery
Yie Kie, C. (Recipient), Yeong, K. Y. (Recipient), Joo Kheng, Emily, G. (Recipient), Yau Yan, L. (Recipient), Yuen Lin, C. (Recipient), Chee Wei, A. (Recipient), Kooi Yeong, K. (Recipient), Ahemad, N. (Recipient), Robinson, A. (Recipient), Andrews, P. (Recipient), Prasetyoputri, A. (Recipient), Ahmad Kamil Hj Mohd Jaafar (Recipient) & Zainal Baharum (Recipient), 22 Jul 2022
Prize: Prize (including medals and awards)
File -
Golden Pavilion (Sanggar Sanjung) Award for Best Research Project - University Science Malaysia
Yeong, K. Y. (Recipient), 2015
Prize: Prize (including medals and awards)
-
Golden Pavilion (Sanggar Sanjung) Award for Best Thesis - University Science Malaysia
Yeong, K. Y. (Recipient), 2016
Prize: Prize (including medals and awards)
Activities
-
Petru Poni Institute of Macromolecular Chemistry
Yeong, K. Y. (Visiting researcher)
Jan 2024 → Feb 2024Activity: Visiting an external institution types › Visiting an external academic institution
-
University of Northern British Columbia
Yeong, K. Y. (Visiting researcher)
Jun 2024 → Sept 2024Activity: Visiting an external institution types › Visiting an external academic institution
-
Member - Royal Society of Chemistry
Yeong, K. Y. (Fellow)
2022 → …Activity: External Academic Engagement › Professional association or peak discipline body
-
University of Queensland
Yeong, K. Y. (Visiting researcher)
Jan 2019 → Feb 2019Activity: Visiting an external institution types › Visiting an external academic institution
-
Member - Malaysia Institute of Chemistry and Committee Member - Division of Green and Sustainable Chemistry, Malaysian Institute of Chemistry
Yeong, K. Y. (Fellow)
2018 → …Activity: External Academic Engagement › Professional association or peak discipline body
Press/Media
-
SUSTAINABLE DRUG DISCOVERY: PLANT WASTES TO HIGH-VALUE BIOACTIVE FEEDSTOCKS
29/04/22
1 Media contribution
Press/Media: Article/Feature
-
TEDxMonashUniversityMalaysia - Trends in drug discovery and development
7/10/17
1 Media contribution
Press/Media: Public Engagement Activities
-
Advancing the field of Medicinal Chemistry
14/07/17
1 Media contribution
Press/Media: Profile/Interview